8-KThe WireStrategic
Material Agreement · Agreement Terminated
Filed Jun 5, 2025 · 1y ago · Accession 0001193125-25-135378
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
(Date of earliest event reported)
Date of Report: June 5, 2025
OWENS & MINOR, INC.
(Exact name of Registrant as specified in charter)
Virginia
001-09810
54-1701843
(State or other jurisdiction
of incorporation)
(Commission
file number)
(I.R.S. employer
identification no.)
10900 Nuckols Road , Suite 400 ,
Glen Allen , Virginia
23060
(Address of principal executive offices)
(Zip code)
Post Office Box 27626,
Richmond, Virginia
23261-7626
(Mailing address of principal executive offices)
(Zip code)
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, $2 par value per share
OMI
New York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01.
Entry Into a Material Definitive Agreement.
The disclosure set forth below under Item 1.02 of this Current Report on Form 8-K is incorporated by reference herein.
Item 1.02.
Termination of a Material Definitive Agreement.
As previously disclosed, on July 22, 2024, Owens & Minor, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Rotech Healthcare Holdings Inc., a Delaware corporation (“Rotech”), Hitchcock Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”) and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative of the equityholders of Rotech (“Representative”), pursuant to which the Company agreed to acquire Rotech on the terms and subject to the conditions therein.
On June 3, 2025, the Company, Rotech and Merger Sub mutually agreed to terminate the Merger Agreement and entered into a mutual termination agreement (the “Termination Agreement”) effective as of the execution of the Termination Agreement and receipt by Rotech (or its applicable designee) of the Termination Fee (as defined below). The mutual termination of the Merger Agreement was approved by the Company’s and Rotech’s respective Boards of Directors. In accordance with the terms of the Termination Agreement, on June 5, 2025, the Company has made a cash payment to Rotech of eighty million dollars ($80,000,000) (the “Termination Fee”). The Termination Fee is the sole and exclusive remedy of the Company for any claims in connection with the Merger Agreement, and the Company and Rotech have each waived any and all other claims in connection with the Merger Agreement and the transactions contemplated thereby.
The foregoing description of the Merger Agreement and the Termination Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Merger Agreement, which was previously filed as Exhibit 2.1 to our Current Report on Form 8-K on July 23, 2024, and the full text of the Termination Agreement, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.
Item 8.01
Other Information
On June 5, 2025, the Company issued a press release announcing the mutual termination of the Merger Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are filed herewith:
Exhibit
Description
10.1
Termination Agreement, dated as of June 3, 2025, by and among Owens & Minor, Inc., Rotech Healthcare Holdings Inc., and Hitchcock Merger Sub Inc.
99.1
Press Release, dated as of June 5, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OWENS & MINOR, INC.
Date: June 5, 2025
By:
/s/ Heath H. Galloway
Name:
Heath H. Galloway
Title:
Executive Vice President, General Counsel & Corporate Secretary
Filing details
- Company
- ACCENDRA HEALTH INC/VA/
- Ticker
- ACH
- CIK
- 75252
- Form type
- 8-K
- Filing date
- Jun 5, 2025
- Report date
- Jun 5, 2025
- Document
- d46460d8k.htm
- Size
- 181 KB